Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: A prospective longitudinal MRI study

American Journal of Psychiatry

Volumn 170, Issue 6, 2013, Pages 609-615

  Andreasen, Nancy C ^a   Liu, Dawei ^a   Ziebell, Steven ^a   Vora, Anvi ^a   Ho, Beng Choon ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRAIN REGION; BRAIN SIZE; BRAIN TISSUE LOSS; DISEASE ASSOCIATION; DISEASE DURATION; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM PARAMETERS; NEUROANATOMY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; SCHIZOPHRENIA; BRAIN; DRUG EFFECT; PATHOLOGY; RECURRENT DISEASE; TIME;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; PROSPECTIVE STUDIES; RECURRENCE; SCHIZOPHRENIA; TIME FACTORS; YOUNG ADULT;

EID: 84881023245     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2013.12050674     Document Type: Article

References (43)

1. Murray CJL, Lopez AD, Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, Mass, Harvard University Press, 1996
2. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E: The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 2008; 165: 1015-1023
3. Nopoulos P, Torres I, Flaum M, Andreasen NC, Ehrhardt JC, Yuh WTC: Brain morphology in first-episode schizophrenia. Am J Psychiatry 1995; 152: 1721-1723
4. Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M: Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 2003; 60: 585-594
5. Lim KO, Tew W, Kushner M, Chow K, Matsumoto B, DeLisi LE: Cortical gray matter volume deficit in patients with first-episode schizophrenia. Am J Psychiatry 1996; 153: 1548-1553
6. Kasai K, Shenton ME, Salisbury DF, Hirayasu Y, Onitsuka T, Spencer MH, Yurgelun-Todd DA, Kikinis R, Jolesz FA, McCarley RW: Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 2003; 60: 766-775
7. DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R: Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res 1997; 74: 129-140
8. Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, Gur RC: A follow-up magnetic resonance imaging study of schizophrenia: relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry 1998; 55: 145-152
9. Lieberman J, Chakos M, Wu H, Alvir J, Hoffman E, Robinson D, Bilder R: Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry 2001; 49: 487-499
10. Whitford TJ, Grieve SM, Farrow TF, Gomes L, Brennan J, Harris AW, Gordon E, Williams LM: Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage 2006; 32: 511-519
11. Cahn W, Hulshoff Pol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA, Schothorst PF, van Engeland H, Kahn RS: Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry 2002; 59: 1002-1010
12. Andreasen NC, Nopoulos P, Magnotta V, Pierson R, Ziebell S, Ho BC: Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry 2011; 70: 672-679
13. Castle DJ, Murray RM: The neurodevelopmental basis of sex differences in schizophrenia. Psychol Med 1991; 21: 565- 575
14. Fish B, Marcus J, Hans SL, Auerbach JG, Perdue S: Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect: a review and replication analysis of pandysmaturation in the Jerusalem Infant Development Study. Arch Gen Psychiatry 1992; 49: 221-235
15. Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660-669
16. Feinberg I: Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1982- 1983; 17: 319-334
17. Andreasen N, Nasrallah HA, Dunn V, Olson SC, Grove WM, Ehrhardt JC, Coffman JA, Crossett JH: Structural abnormalities in the frontal system in schizophrenia: a magnetic resonance imaging study. Arch Gen Psychiatry 1986; 43: 136-144
18. Wyatt RJ: Early intervention for schizophrenia: can the course of the illness be altered? Biol Psychiatry 1995; 38: 1-3
19. Ho BC, Alicata D, Mola C, Andreasen NC: Hippocampus volume and treatment delays in first-episode schizophrenia. Am J Psychiatry 2005; 162: 1527-1529
20. Ho B-C, Andreasen NC, Flaum M, Nopoulos P, Miller D: Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry 2000; 157: 808-815
21. McEwen BS: Effects of adverse experiences for brain structure and function. Biol Psychiatry 2000; 48: 721-731
22. Csernansky JG, Mahmoud R, Brenner R; Risperidone-USA-79 Study Group: A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Engl J Med 2002; 346: 16-22
23. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V: Longterm antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 2011; 68: 128-137
24. Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC: Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 2010; 67: 255-262
25. Dorph-Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA: The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 2005; 30: 1649-1661
26. Konopaske GT, Dorph-Petersen KA, Pierri JN, Wu Q, Sampson AR, Lewis DA: Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology 2007; 32: 1216-1223
27. Vernon AC, Natesan S, Modo M, Kapur S: Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation. Biol Psychiatry 2011; 69: 936-944
28. Andreasen NC, Flaum M, Arndt S: The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 1992; 49: 615-623
29. Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR: Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005; 162: 441-449
30. Andreasen NC: The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, Iowa, University of Iowa, 1984
31. Andreasen NC: The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, Iowa, University of Iowa, 1984
32. Andreasen NC, Cizadlo T, Harris G, Swayze V 2nd, O'Leary DS, Cohen G, Ehrhardt J, Yuh WT: Voxel processing techniques for the antemortem study of neuroanatomy and neuropathology using magnetic resonance imaging. J Neuropsychiatry Clin Neurosci 1993; 5: 121-130
33. Andreasen NC, Rajarethinam R, Cizadlo T, Arndt S, Swayze VW 2nd, Flashman LA, O'Leary DS, Ehrhardt JC, Yuh WT: Automatic atlas-based volume estimation of human brain regions from MR images. J Comput Assist Tomogr 1996; 20: 98-106
34. Harris G, Andreasen NC, Cizadlo T, Bailey JM, Bockholt HJ, Magnotta VA, Arndt S: Improving tissue classification in MRI: a three-dimensional multispectral discriminant analysis method with automated training class selection. J Comput Assist Tomogr 1999; 23: 144-154
35. Magnotta VA, Andreasen NC, Schultz SK, Harris G, Cizadlo T, Heckel D, Nopoulos P, Flaum M: Quantitative in vivo measurement of gyrification in the human brain: changes associated with aging. Cereb Cortex 1999; 9: 151-160
36. Magnotta VA, Bockholt HJ, Johnson HJ, Christensen GE, Andreasen NC: Subcortical, cerebellar, and magnetic resonance based consistent brain image registration. Neuroimage 2003; 19: 233-245
37. Magnotta VA, Harris G, Andreasen NC, O'Leary DS, Yuh WT, Heckel D: Structural MR image processing using the BRAINS2 toolbox. Comput Med Imaging Graph 2002; 26: 251-264
38. Magnotta VA, Heckel D, Andreasen NC, Cizadlo T, Corson PW, Ehrhardt JC, Yuh WT: Measurement of brain structures with artificial neural networks: two- and three-dimensional applications. Radiology 1999; 211: 781-790
39. Pierson R, Johnson H, Harris G, Keefe H, Paulsen JS, Andreasen NC, Magnotta VA: Fully automated analysis using BRAINS: AutoWorkup. Neuroimage 2011; 54: 328-336
40. Ho BC, Flaum M, Hubbard W, Arndt S, Andreasen NC: Validity of symptom assessment in psychotic disorders: information variance across different sources of history. Schizophr Res 2004; 68: 299-307
41. Keshavan MS: Development, disease, and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res 1999; 33: 513-521
42. Velakoulis D, Wood SJ, McGorry PD, Pantelis C: Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental model. Aust N Z J Psychiatry 2000; 34(suppl):S113-S126
43. Nuechterlein KH, Dawson ME, Ventura J, Gitlin M, Subotnik KL, Snyder KS, Mintz J, Bartzokis G: The vulnerability/stress model of schizophrenic relapse: a longitudinal study. Acta Psychiatr Scand Suppl 1994; 382: 58-64